The Promise Of Paxlovid
Bloomberg Businessweek|April 04, 2022
If Pfizer’s Covid-19 treatment is to help end the pandemic, more nations need rapid access
Cynthia Koons, Rebecca Penty, and Rick Schine
The Promise Of Paxlovid

When Pfizer Inc. revealed the efficacy of its Covid pill last November, the excitement was palpable. Scientists hailed Paxlovid as a breakthrough. World leaders raced to lock up supplies. But just three months into the rollout, optimism about the drug’s ability to help bring a swift end to the pandemic is waning, as fears mount that unequal distribution will exacerbate the challenge of getting the virus under control.

It’s too soon to say whether this will end up being as inequitable as the botched vaccine deployment. Mass quantities of the therapy may take more than a year to become available because of production and regulatory hurdles, according to drug experts. After wealthy nations snapped up a large share of initial supplies of Paxlovid, which slashed the risk of hospitalization and death from Covid- 19 by 89% in clinical trials, many low- and middle-income countries are facing a potentially long wait for generic versions.

“We’ve already had those discussions with vaccines,” says Borna Nyaoke-Anoke, a doctor and researcher in Kenya with the Drugs for Neglected Diseases Initiative, a nonprofit. “It’s quite unfortunate that we need to have them again.”

With thousands of Covid deaths a day, time is the one thing the world doesn’t have. Whenever the virus starts to subside, new variants or subvariants pop up, causing fresh spikes in cases. Knowing the critical role Pfizer’s drug could play in quashing the virus, health organizations, researchers, and companies are working to accelerate Paxlovid production beyond what is currently forecast and bring down the high cost of manufacturing.

This story is from the April 04, 2022 edition of Bloomberg Businessweek.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the April 04, 2022 edition of Bloomberg Businessweek.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BLOOMBERG BUSINESSWEEKView All
Instagram's Founders Say It's Time for a New Social App
Bloomberg Businessweek US

Instagram's Founders Say It's Time for a New Social App

The rise of AI and the fall of Twitter could create opportunities for upstarts

time-read
4 mins  |
March 13, 2023
Running in Circles
Bloomberg Businessweek US

Running in Circles

A subscription running shoe program aims to fight footwear waste

time-read
3 mins  |
March 20 - 27, 2023
What I Learned Working at a Hawaiien Mega-Resort
Bloomberg Businessweek US

What I Learned Working at a Hawaiien Mega-Resort

Nine wild secrets from the staff at Turtle Bay, who have to manage everyone from haughty honeymooners to go-go-dancing golfers.

time-read
10 mins  |
March 20 - 27, 2023
How Noma Will Blossom In Kyoto
Bloomberg Businessweek US

How Noma Will Blossom In Kyoto

The best restaurant in the world just began its second pop-up in Japan. Here's what's cooking

time-read
3 mins  |
March 20 - 27, 2023
The Last-Mover Problem
Bloomberg Businessweek US

The Last-Mover Problem

A startup called Sennder is trying to bring an extremely tech-resistant industry into the age of apps

time-read
10+ mins  |
March 20 - 27, 2023
Tick Tock, TikTok
Bloomberg Businessweek US

Tick Tock, TikTok

The US thinks the Chinese-owned social media app is a major national security risk. TikTok is running out of ways to avoid a ban

time-read
10+ mins  |
March 20 - 27, 2023
Cleaner Clothing Dye, Made From Bacteria
Bloomberg Businessweek US

Cleaner Clothing Dye, Made From Bacteria

A UK company produces colors with less water than conventional methods and no toxic chemicals

time-read
3 mins  |
March 20 - 27, 2023
Pumping Heat in Hamburg
Bloomberg Businessweek US

Pumping Heat in Hamburg

The German port city plans to store hot water underground and bring it up to heat homes in the winter

time-read
3 mins  |
March 20 - 27, 2023
Sustainability: Calamari's Climate Edge
Bloomberg Businessweek US

Sustainability: Calamari's Climate Edge

Squid's ability to flourish in warmer waters makes it fitting for a diet for the changing environment

time-read
4 mins  |
March 20 - 27, 2023
New Money, New Problems
Bloomberg Businessweek US

New Money, New Problems

In Naples, an influx of wealthy is displacing out-of-towners lower-income workers

time-read
4 mins  |
March 20 - 27, 2023